Skip to main content

Case Study Highlights Critical Need for Third‑Trimester Syphilis Screening in Carceral Settings to Prevent Congenital Syphilis 

March 2, 2026
Chapel Hill, NC— A newly published case study in the Journal of Correctional Health Care urges immediate action to strengthen syphilis screening protocols for pregnant individuals in U.S. jails and prisons. Researchers at the Institute for Global Health and Infectious Diseases recently published “Syphilis Screening Among Pregnant Individuals in Carceral...

Study Warns of Underrecognized Lassa Fever Threat with Global Implications

January 27, 2026
Chapel Hill, NC—A new study led by researchers at the Institute for Global Health and Infectious Diseases at the University of North Carolina School of Medicine in Chapel Hill shows an urgent need for improved detection and treatment of Lassa fever, published in The Lancet Infectious Diseases. Lassa fever–a severe...

New Once Weekly Investigational Oral Regimen Shows Strong 48 Week Results, Highlighting the Need for Easier HIV Treatment Options

January 16, 2026
Chapel Hill, N.C. — A Phase 2 study led by Dr. Joe Eron, a member of the UNC Institute for Global Health and Infectious Diseases, shows an investigational once‑weekly, all‑oral combination of islatravir (ISL) and lenacapavir(LEN) maintains high levels of virologic suppression through 48 weeks in adults living with HIV....

Innovative Network Mapping Combined with Community Driven Initiatives Strengthen HIV Prevention and Care in the Carolinas

January 6, 2026
Since 2008, new HIV diagnoses in the US have been reduced by about half; however, progress is not equally distributed. In 2022, only about 65% of people diagnosed with HIV in the US—and North Carolina—were virally suppressed, falling short of the national target of 95% viral suppression. Southern states, including...

Lymphoma Study Shows Increased Malaria Risk with Rituximab Treatment

January 6, 2026
Chapel Hill, NC — Researchers with the UNC Institute for Global Health and Infectious Diseases (IGHID), in collaboration with the UNC Lineberger Comprehensive Cancer Center, and UNC Project-Malawi, found adults receiving rituximab as part of cancer treatment face a significantly higher risk of developing symptomatic malaria in an endemic region....

UNC Vietnam Publishes Landmark Findings: A Tailored Implementation Approach Improves HIV Intervention for People Who Inject Drugs in Vietnam

January 4, 2026
A UNC Vietnam team led by Vivian Go, PhD, and Bill Miller, MD, PhD, researchers with the UNC Institute for Global Health and Infectious Diseases–in collaboration with Hanoi Medical University and the Vietnam Ministry of Health–found that tailoring implementation strategies to local clinic needs significantly improved the delivery of a...

Study Shows Clear Link Between Alcohol Use and Poor HIV Outcomes After Prison Release  

December 19, 2025
Chapel Hill, NC – New research published in JAMA Network Open highlights a critical challenge facing people living with HIV as they re-enter the community after incarceration. A Zambia study led by Michael Herce, MD, MPH, MSCR, an investigator at the UNC Institute for Global Health and Infectious Diseases—in collaboration with colleagues...

Champions for the HIV Workforce, Service to North Carolina

December 7, 2025
Every community has unsung heroes, and in the HIV-care community there are many. Cassandra Durham is a fierce advocate for the HIV workforce whose dedication is reshaping what it means to care for people with HIV. A personal experience supporting a friend with HIV in the early 1990s—seeing his food...

From Toronto to Tigray: IDEEL Investigators Advance Global Conversation on Malaria Control Amid Rising Challenges

December 1, 2025
The American Society of Tropical Medicine and Hygiene’s (ASTMH) Annual Meeting, Nov. 9-13 in Toronto, Ontario, Canada, drew approximately 4,900 global health professionals from around the world. Investigators from the IDEEL Lab contributed new insights to the global conversation, drawing attention to a defining crossroads in East Africa’s malaria response....

Neighborhood Deprivation Drives Higher Antimicrobial Resistance and Mortality in Enterobacterales Infections

November 20, 2025
High neighborhood deprivation is linked to both greater antimicrobial resistance and higher short‑term mortality in Enterobacterales infections. For North Carolina, the implications are clear. Tackling AMR requires not only new drugs and diagnostics but also addressing healthcare disparities that leave vulnerable populations at greater risk. Chapel Hill, NC — A...

Fischer, WHO Clinical Team Demonstrate Critical Care Can Be Delivered Safely for Marburg Patients

November 11, 2025
Landmark research led by William Fischer II, MD, director of emerging pathogens for the UNC Institute for Global Health and Infectious Diseases, describes the successful delivery of advanced care to patients with Marburg virus disease during Rwanda’s third largest outbreak on record, published in The Lancet Infectious Diseasesand The New...

The Lone star Tick & One Patient’s Experience With Ehrlichiosis

October 8, 2025
In a recent podcast, The Lone Star Tick & One Patient’s Experience With Ehrlichiosis, Dr. Ron Falk speaks with Dr. Ross Boyce, an expert in tick-borne illnesses, and Dr. Katherine Huffman-Falk, a retired nephrologist who was recently bitten by a tick. This podcast talks about what a tick-borne disease is...